News | April 23, 2012

bioRASI To Sponsor The Evolution Summit 2012 In Chicago, USA

The Leading Global CRO to Showcase Clinical Research Optimization Techniques at the Industry's most exclusive conference

bioRASI, a full service, global Contract Research Organization (CRO), will participate as a premier sponsor of the Annual Evolution Summit 2012 in Chicago, Illinois on April 30th -May 2nd.  bioRASI will be showcasing its unique and powerful optimization strategies and solutions, designed to overcome the multifaceted challenges facing today's complex clinical development programs.

The Annual Evolution Summit, an exclusive industry gathering, brings together the most esteemed opinion leaders from all over the world to focus on delivering optimized solutions for the ever-increasing challenges within the pharmaceutical industry.

"Our Sponsors want their clinical programs optimized and we deliver. Our Program Optimization Service Branch has emerged as the most unique and powerful organization in the CRO industry," said Boris Reznik, PhD, Chairman of bioRASI. "Our optimization techniques are focused on a multidimensional set of criteria that includes time, costs, service level, industry acceptance and, of course, quality."

The Program Optimization Service Branch consists of scientists with business strengths and of business people with scientific strengths. Everybody involved is committed to a deep and fundamental understanding of the "Lab" sciences, preclinical and IND enablement processes and fully equipped with the Phase I through Phase III programs optimization techniques. "In addition, our understanding and capacity to navigate the peculiarities of different regulatory jurisdictions coupled with our longstanding relationships with well-respected opinion leaders, Principal Investigators, clinical sites are what drive bioRASI's ability to deliver global trial excellence," Dr. Reznik continued.  

About bioRASI, LLC
bioRASI is an award-winning Full Service Global CRO providing clinical development that optimizes its sponsors scientific, clinical, and business results. bioRASI facilitates obtaining drugs, biotherapeutics, and medical devices marketing approvals by delivering high quality regulatory and clinical strategies, solutions and services. The Company's unique access to the largest facilities and patient populations all over the world saves their clients critical time. bioRASI's services include program optimization, project management, regulatory, clinical, data management and analysis, compliance and audit. bioRASI is headquartered in Aventura, FL and has regional offices and operations across North America and around the world.

SOURCE: bioRASI, LLC